Test Price
2,800 AED✅ Home Collection Available
WDR27 Gene Sequencing for Neurological Disorders | Genetic Test in UAE | 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
The WDR27 full gene sequencing test employs next-generation sequencing (NGS) technology to deliver precise genetic diagnosis for hereditary neurological disorders, achieving 99.9% diagnostic sensitivity through ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139). This analysis supports clinicians and families in making informed therapeutic and counseling decisions.
- ●Accuracy Guarantee: 99.9% diagnostic sensitivity with single-nucleotide resolution across all coding exons and flanking intronic regions.
- ●Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- ●Clinical Guidance: Telephonic post-test result interpretation by a DHA-licensed Consultant Medical Genetics specialist.
- ●Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The WDR27 gene NGS test comprehensively screens the entire coding region of the WDR27 gene for pathogenic variants linked to hereditary brain disorders, including neurodevelopmental delay, ataxia, microcephaly, and structural brain malformations. This assay is essential for confirming a genetic diagnosis, guiding treatment planning, and enabling accurate family counseling.
| Feature | Our Test (NGS Full Gene Sequencing) | Closest Alternative (Targeted Sanger Sequencing) |
|---|---|---|
| Precision | Single-nucleotide resolution across all exons + 20 bp intronic flanking regions; detects SNVs, indels, and CNVs | Limited to known hotspot mutations; may miss large rearrangements |
| Methodology | Illumina NovaSeq X Plus with dual-index deduplication and clinically validated bioinformatics pipeline | Sanger sequencing with lower multiplex capacity |
| Speed | 3–4 Weeks (expedited available) | 6–8 Weeks |
Physician Insight & Safety Protocols
“Genetic testing for neurological disorders can bring both clarity and emotional weight. This result is one piece of your complete clinical picture and must be interpreted alongside neurological examination, brain imaging, and family history. Our multidisciplinary team is committed to guiding you through every finding with empathy and precision—please reach out with any questions.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Medication Advisory
Do not stop, adjust, or initiate any prescribed therapy—including antiepileptics, corticosteroids, or neuroprotective agents—without prior consultation with your treating physician. Abrupt medication changes may lead to neurological decline or withdrawal-related complications.
Exclusion Criteria & ER Red Flags
- Exclusion: Patients unable to provide informed consent; minors without legal guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability; active untreated infection at the blood collection site.
- ER Red Flags: Sudden severe headache with altered consciousness, new-onset seizures, abrupt vision loss or unsteady gait, signs of increased intracranial pressure (vomiting, papilledema). If any of these occur, proceed to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What conditions are targeted by the WDR27 gene sequencing test?
The WDR27 gene sequencing test identifies pathogenic variants responsible for autosomal recessive spinocerebellar ataxia, microcephaly, developmental brain malformations, and neurodevelopmental disorders. This test confirms a genetic diagnosis in patients with unexplained cerebellar ataxia or structural brain anomalies and supports family planning through accurate carrier detection.
2. How long does it take to receive results and is fasting required?
Results are finalized within 3 to 4 weeks from sample receipt. Fasting is not required for blood or FTA card collection; the sample can be collected at any time. The final report is delivered via a secure electronic portal with a detailed clinical interpretation.
3. Does health insurance in the UAE cover the cost of this genetic test?
Coverage depends on your specific insurance plan. Our team provides direct billing verification and pre-authorization support via WhatsApp at +971 54 548 8731 to ensure full financial transparency before the test is performed.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This diagnostic service is delivered in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | WDR27 Gene Sequencing for Neurological Disorders |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina NovaSeq X Plus |
| ICD-10-CM Code | G11.8, Q04.8 |
| LOINC Code | 81322-1 |
| DHA Facility License & Laboratory Address | License #1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians